Reports for SANDOZ CANADA INCORPORATED

Company Name

SANDOZ CANADA INCORPORATED

Totals

Shortage reports

2123

Actual shortage: 50 (2%)
Anticipated shortage: 9 (0%)
Avoided shortage: 19 (1%)
Resolved: 2045 (96%)

Discontinuation Reports

101

To be discontinued: 1 (1%)
Discontinued: 98 (97%)
Reversed: 2 (2%)

Late reports

444 (20%)

Overdue reports

38 (63%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
SANDOZ VORICONAZOLE 200MG TABLET Resolved 2023-05-30 2023-06-20 193399
SANDOZ VORICONAZOLE 50MG TABLET Resolved 2023-04-18 2023-06-20 189804
SANDOZ ZOLMITRIPTAN 2.5MG TABLET Resolved 2024-08-05 2024-10-22 234502
SANDOZ ZOLMITRIPTAN 2.5MG TABLET Resolved 2024-08-20 2024-10-21 235574
SANDOZ ZOLMITRIPTAN 2.5MG TABLET Actual shortage 2025-05-05 2025-05-06 256693
SANDOZ ZOLMITRIPTAN 2.5MG TABLET Resolved 2022-07-20 2022-08-20 165137
SANDOZ ZOLMITRIPTAN 2.5MG TABLET Resolved 2022-10-19 2022-11-29 172202
SANDOZ ZOLMITRIPTAN 2.5MG TABLET Resolved 2022-11-02 2022-11-17 173391
SANDOZ ZOLMITRIPTAN 2.5MG TABLET Resolved 2023-05-15 2023-08-01 192573
SANDOZ ZOLMITRIPTAN 2.5MG TABLET Resolved 2018-10-09 2019-01-16 63518
SANDOZ ZOLMITRIPTAN 2.5MG TABLET Resolved 2019-02-18 2019-05-01 76192
SANDOZ ZOLMITRIPTAN ODT 2.5MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-04-13 2018-10-17 45800
SANDOZ ZOLMITRIPTAN ODT 2.5MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-04-20 2019-01-16 46803
SANDOZ ZOLMITRIPTAN ODT 2.5MG TABLET (ORALLY DISINTEGRATING) Actual shortage 2025-04-24 2025-04-24 255536
SANDOZ ZOLMITRIPTAN ODT 2.5MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-03-20 2023-10-03 187457
SANDOZ ZOLMITRIPTAN ODT 2.5MG TABLET (ORALLY DISINTEGRATING) Resolved 2021-11-03 2021-11-09 148770
SANDOZ ZOLMITRIPTAN ODT 2.5MG TABLET (ORALLY DISINTEGRATING) Actual shortage 2024-04-23 2025-01-20 225976
SANDOZ ZOLMITRIPTAN ODT 2.5MG TABLET (ORALLY DISINTEGRATING) Resolved 2024-06-12 2025-04-24 230196
SANDOZ ZOLMITRIPTAN ODT 2.5MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-08-14 2023-09-12 201769
SANDOZ ZOLMITRIPTAN ODT 2.5MG TABLET (ORALLY DISINTEGRATING) Resolved 2022-08-03 2022-08-20 165986

Showing 1961 to 1980 of 2123

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ALFENTANIL INJECTION USP Discontinued 2019-10-15 2019-10-15 96610
ATRACURIUM BESYLATE INJECTION Discontinued 2019-10-15 2019-10-15 96613
BETAJECT Discontinued 2019-10-15 2019-10-15 96616
BLUE COLLYRIUM Discontinued 2019-10-15 2019-10-15 96619
BRETYLIUM TOSYLATE INJECTION USP Discontinued 2020-04-01 2020-04-01 110288
BRETYLIUM TOSYLATE INJECTION USP 50MG SOLUTION Discontinued 2017-12-06 2017-12-06 31958
CLINDAMYCIN INJECTION USP 150MG LIQUID Discontinued 2017-06-06 2017-10-18 12122
CODEINE PHOSPHATE INJECTION USP 30MG LIQUID Discontinued 2022-04-20 2022-04-20 159064
COMTAN 200MG TABLET Discontinued 2022-03-03 2022-03-04 155940
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Discontinued 2018-08-27 2019-01-02 59179
FOLIC ACID INJECTION USP 5MG LIQUID To be discontinued 2019-05-01 2019-05-01 82956
FOLIC ACID INJECTION USP 5MG LIQUID Discontinued 2020-01-28 2020-01-28 104481
HEPARIN SODIUM INJECTION USP (SINGLE USE VIAL-PRESERVATIVE FREE) 10000UNIT SOLUTION Discontinued 2018-07-04 2018-07-31 54349
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2024-05-17 2024-05-18 228249
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2023-10-18 2023-10-19 207275
IMIPENEM AND CILASTATIN FOR INJECTION USP 250MG 250MG POWDER FOR SOLUTION Discontinued 2021-08-23 2021-08-23 144467
LORAZEPAM INJECTION USP 2MG SOLUTION Discontinued 2020-02-14 2020-03-12 106265
MICRO PLUS 6 (CONCENTRATE) 75MCG 60MCG 10MCG 0.5MG 1MG 5MG LIQUID Discontinued 2021-10-25 2021-10-26 147927
MILRINONE LACTATE INJECTION 1MG SOLUTION Discontinued 2022-06-17 2022-06-18 163000
OLANZAPINE FOR INJECTION 10MG POWDER FOR SOLUTION Discontinued 2020-06-22 2020-06-22 118553

Showing 1 to 20 of 101